Comparison of Prostate IMRT and VMAT Biologically Optimised Treatment Plans

Medical Dosimetry

Volumn 36, Issue 3, 2011, Pages 292-298

  Hardcastle, Nicholas ^a,b   Tomé, Wolfgang A ^a,b   Foo, Kerwyn ^a,c   Miller, Andrew ^a,c   Carolan, Martin ^c   Metcalfe, Peter ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c WOLLONGONG HOSPITAL   (Australia)

Author keywords

Biological optimisation; IMRT; Prostate; VMAT

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; NORMAL TISSUE COMPLICATION PROBABILITY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; RADIOLOGICAL PARAMETERS; RECTUM; TREATMENT PLANNING; VOLUMETRIC MODULATED ARC THERAPY;

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 79960901457     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2010.06.001     Document Type: Article

References (37)

1. Kupelian P.A., Reddy C.A., Carlson T.P., et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53:904-912.
2. Kupelian P.A., Reddy C.A., Carlson T.P., et al. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: Absolute or relative rectal volume?. Cancer J. 2002, 8:62-66.
3. Namiki S., Ishidoya S., Tochigi T., et al. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: Comparison with conventional and conformal radiotherapy. Japan. J. Clin. Oncol. 2006, 36:224-230.
4. Sanguineti G., Cavey M.L., Endres E.J., et al. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate only radiotherapy to 76 Gy?. Strahlenther. Onkol. 2006, 182:543-549.
5. Veldeman L., Madani I., Hulstaert F., et al. Evidence behind use of intensity-modulated radiotherapy: A systematic review of comparative clinical studies. Lancet Oncol. 2008, 9:367-375.
6. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother. Oncol. 2000, 55:241-249.
7. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J. Urol. 2001, 166:876-881.
8. Bzdusek K., Friberger H., Eriksson K., et al. Development and evaluation of an efficient approach to volumetric arc therapy planning. Med. Phys. 2009, 36:2328-2339.
9. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 2008, 35:310-317.
10. Yu C.X. Intensity-modulated arc therapy with dynamic multileaf collimation-an alternative to tomotherapy. Phys. Med. Biol. 1995, 40:1435-1449.
11. Palma D., Vollans E., James K., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: Comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:996-1001.
12. Palma D., Vollans E., James K., et al. Volumetric modulated arc therapy (VMAT) for delivery of prostate radiotherapy: Reduction in treatment time and monitor unit requirements compared to intensity modulated radiotherapy 2008, 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA.
13. Wolff D., Stieler F., Abo-Madyan Y., et al. Volumetric intensity modulated arc therapy (VMAT) vs. serial tomotherapy and segmental (step and shoot) IMRT for treatment of prostate cancer 2008, 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA.
14. Wolff D., Stieler F., Welzel G., et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother. Oncol. 2009, 93:226-233.
15. Zhang P., Happersett L., Hunt M., et al. Volumetric modulated arc therapy: Planning and evaluation for prostate cancer cases. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:1456-1462.
16. Kjaer-Kristoffersen F., Ohlhues L., Medin J., et al. RapidArc volumetric modulated therapy planning for prostate cancer patients 2008, Symposium of the Nordic Association of Clinical Physics, Arhaus, Denmark.
17. Bortfeld T., Webb S. Single-arc IMRT?. Phys. Med. Biol. 2009, 54:N9-N20.
18. Bortfeld T., Webb S. Reply to "Comments on Single-Arc IMRT"?. Phys. Med. Biol. 2009, 54:L35-L36.
19. Bortfeld T., Webb S. Reply to letter to the editor on "Single-Arc IMRT"?. Phys. Med. Biol. 2009, 54:L43-L44.
20. Otto K. Letter to the editor on "Single-Arc IMRT"?. Phys. Med. Biol. 2009, 54:L37-L41.
21. Verbakel W., Senan S., Lagerwaard F.J., et al. Comments on "Single-Arc IMRT"?. Phys. Med. Biol. 2009, 54:L31-L34.
22. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:67-74.
23. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53:1097-1105.
24. Biological Optimization using the Equivalent Uniform Dose (EUD) in Pinnacle3 2003, RaySearch Laboratories AB, Stockholm, Sweden.
25. I.E. Commission (editor). Radiotherapy equipment-coordinates, movements and scales. In IEC1217, 1996, International Electrotechnical Commission.
26. Feygelman V., Zhang G., Stevens C. Initial dosimetric evaluation of SmartArc-a novel VMAT treatment planning module implemented in a multi-vendor delivery chain. J. Appl. Clin. Med. Phys. 2010, 11:99-116.
27. Bortfeld T., Schlegel W., Rhein B. Decomposition of pencil beam kernels for fast dose calculations in 3-dimensional treatment planning. Med. Phys. 1993, 20:311-318.
28. McNutt T. Dose calculations: Collapsed cone convolution superposition and delta pixel beam 2002, Philips Healthcare.
29. Deasy J.O., Blanco A.I., Clark V.H. CERR: A computational environment for radiotherapy research. Med. Phys. 2003, 30:979-985.
30. Kutcher G.J., Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation-the effective volume method. Int. J. Radiat. Oncol. Biol. Phys. 1989, 16:1623-1630.
31. Lyman J.T. Complication probability as assessed from dose volume histograms. Radiat. Res. 1985, 104:S13-S19.
32. Tucker S.L., Dong L., Cheung R., et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60:1589-1601.
33. Tucker S.L., Dong L., Bosch W.R., et al. Fit of a generalized Lyman normal-tissue complication probability (NTCP) model to grade >= 2 late rectal toxicity data from patients treated on protocol RTOG 94-06 2007, 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Los Angeles, CA.
34. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101). Radiother. Oncol. 2004, 73:21-32.
35. Ost P., Fonteyne V., De Neve W., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2009, 73:1286. (In regard to Palma, D.; et al. Int. J. Radiat. Oncol. Biol. Phys. 70:996-1001; 2008).
36. Palma D., Moiseenko V., Vollans E., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: Reply to Palma, D. et al. Int. J. Radiat. Oncol. Biol. Phys. 70: 996-1001; 2008). Int. J. Radiat. Oncol. Biol. Phys. 2009, 73:1287.
37. Sohn M., Yan D., Liang J., et al. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:1066-1073.